Summary by Moomoo AI
TC BioPharm (Holdings) plc successfully conducted its 2024 Annual General Meeting (AGM) on July 24, 2024, with all proposed resolutions passed. The AGM saw the approval of the company's annual report and audited financial statements for the year ended December 31, 2023. Shareholders also approved the Directors' Remuneration Report for the same period. Marcum LLP was ratified as the U.S. independent registered public accounting firm for the upcoming year, while Ecovis was re-appointed as the U.K. statutory auditor until the next AGM. Additionally, the Audit Committee was authorized to determine the remuneration of the U.K. statutory auditor for the year ending December 31, 2024. A provision to adjourn the AGM to a later date if necessary was also approved. The full text of each resolution was included in the Notice of Annual General Meeting distributed to shareholders on July 1, 2024, and filed with the U.S. Securities and Exchange Commission.
